(Q46957326)

English

IL28B polymorphisms are markers of therapy response and are influenced by genetic ancestry in chronic hepatitis C patients from an admixed population.

scientific article published on 3 October 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22098416%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

IL28B polymorphisms are markers of therapy response and are influenced by genetic ancestry in chronic hepatitis C patients from an admixed population (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22098416%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

chronic hepatitis C

1 reference

based on heuristic

inferred from title

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22098416%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22098416%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

author name string

Lourianne N Cavalcante

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22098416%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Kiyoko Abe-Sandes

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22098416%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Taisa M B Machado

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22098416%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Denise C Lemaire

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22098416%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Carlos M C Mendes

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22098416%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Luiz G C Lyra

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22098416%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

André C Lyra

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22098416%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Ana Luiza D Angelo

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22098416%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

publication date

3 October 2011

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22098416%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Liver International

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22098416%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

32

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22098416%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22098416%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

476-486

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22098416%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Global epidemiology and burden of hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02653.X

21 January 2018

The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02653.X

21 January 2018

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02653.X

21 January 2018

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02653.X

21 January 2018

Diagnosis, management, and treatment of hepatitis C

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02653.X

21 January 2018

Appendix: The National Institutes of Health Consensus Development Conference Management of Hepatitis C 2002.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02653.X

21 January 2018

Peginterferon and ribavirin treatment in African American and Caucasian American patients with hepatitis C genotype 1.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02653.X

21 January 2018

Hepatitis C infection in African Americans: its natural history and histological progression

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02653.X

21 January 2018

Peginterferon alfa-2b or alfa-2a with ribavirin for treatment of hepatitis C infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02653.X

21 January 2018

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02653.X

21 January 2018

Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02653.X

21 January 2018

IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02653.X

21 January 2018

Impact of IL28B genotype on the early and sustained virologic response in treatment-naïve patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02653.X

21 January 2018

A polymorphism near IL28B is associated with spontaneous clearance of acute hepatitis C virus and jaundice

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02653.X

21 January 2018

Genetic variation in IL28B and spontaneous clearance of hepatitis C virus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02653.X

21 January 2018

Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02653.X

21 January 2018

SNPs in the promoter region of the osteopontin gene as a marker predicting the efficacy of interferon-based therapies in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02653.X

21 January 2018

Natural killer cell receptor and HLA-C gene polymorphisms among patients with hepatitis C: a comparison between sustained virological responders and non-responders

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02653.X

21 January 2018

Treatment responses in Asians and Caucasians with chronic hepatitis C infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02653.X

21 January 2018

An IL28B polymorphism determines treatment response of hepatitis C virus genotype 2 or 3 patients who do not achieve a rapid virologic response

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02653.X

21 January 2018

An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02653.X

21 January 2018

Estimating African American admixture proportions by use of population-specific alleles

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02653.X

21 January 2018

African origin of human-specific polymorphic Alu insertions

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02653.X

21 January 2018

Racial admixture in north-eastern Brazil

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02653.X

21 January 2018

Color and genomic ancestry in Brazilians

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02653.X

21 January 2018

Correcting for measurement error in individual ancestry estimates in structured association tests

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02653.X

21 January 2018

Replicated association between an IL28B gene variant and a sustained response to pegylated interferon and ribavirin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02653.X

21 January 2018

Importance of IL28B gene polymorphisms in hepatitis C virus genotype 2 and 3 infected patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02653.X

21 January 2018

Interleukin-28B genetic variants and hepatitis virus infection by different viral genotypes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02653.X

21 January 2018

Role of interleukin-28B polymorphisms in the treatment of hepatitis C virus genotype 2 infection in Asian patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02653.X

21 January 2018

Rapid and simple detection of IFN-neutralizing antibodies in chronic hepatitis C non-responsive to IFN-α

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02653.X

21 January 2018

GENEPOP (Version 1.2): Population Genetics Software for Exact Tests and Ecumenicism

1 reference

20 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1093/OXFORDJOURNALS.JHERED.A111573

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46957326&oldid=1643800348"